Dr Reddys Laboratories (RDY) Cash from Discontinued Operations (2017 - 2025)
Dr Reddys Laboratories (RDY) recorded quarterly Cash from Discontinued Operations of 170935643.25 in Q2 2025, up 67.83% quarter-over-quarter from 101847581.98 in Q2 2024, and up 67.83% on a YoY basis from 101847581.98 in Q2 2024.
Dr Reddys Laboratories (RDY) Cash from Discontinued Operations (2017 - 2025) Analysis & Trends
Dr Reddys Laboratories' Cash from Discontinued Operations history runs 9 years deep, the most recent figure standing at 170935643.25 for Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Dr Reddys Laboratories | 122.03 Mn | -51.98 Mn | 368.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 170.94 Mn |
| Jun 30, 2025 | 170.94 Mn |
| Jun 30, 2024 | 101.85 Mn |
| Jun 30, 2024 | 101.85 Mn |
| Dec 31, 2023 | 120.34 Mn |
| Dec 31, 2023 | 120.34 Mn |
| Sep 30, 2023 | 216.85 Mn |
| Sep 30, 2023 | 216.85 Mn |
| Jun 30, 2023 | 136.93 Mn |
| Jun 30, 2023 | 136.93 Mn |
| Dec 31, 2022 | 283.31 Mn |
| Dec 31, 2022 | 283.31 Mn |
| Sep 30, 2022 | 116.41 Mn |
| Sep 30, 2022 | 116.41 Mn |
| Jun 30, 2022 | 86.30 Mn |
| Jun 30, 2022 | 86.30 Mn |
| Dec 31, 2021 | 231.31 Mn |
| Dec 31, 2021 | 231.31 Mn |
| Sep 30, 2021 | 68.91 Mn |
| Sep 30, 2021 | 68.91 Mn |